Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients

R. Dobias, P. Jaworska, H. Tomaskova, M. Kanova, P. Lyskova, Z. Vrba, C. Holub, L. Svobodová, P. Hamal, M. Raska,

. 2018 ; 61 (8) : 576-586. [pub] 20180611

Language English Country Germany

Document type Evaluation Study, Journal Article, Multicenter Study

Detection of serum galactomannan (GM) and (1,3)-β-d-glucan (BG) is considered useful for non-culture diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients. Only few studies evaluated these seromarkers in non-neutropenic patients suspected of having IPA. The aim of this study was to evaluate both tests together with the Aspergillus fumigatus-specific serum IgG and IgA (IgAG) test for serological IPA diagnosis in non-neutropenic patients. Sera from 87 patients suspected of having IPA were retrospectively analysed. Patients were categorised into groups of proven IPA (n = 10), putative IPA (n = 31) and non-IPA colonisation (n = 46). When the GM, BG and IgAG assays were used for patients included in the study, the sensitivity/specificity/positive predictive value (PPV)/negative predictive value (NPV) were 48.8%/91.3%/83.3%/66.7%, 82.9%/73.9%/73.9%/82.9% and 75.6%/95.7%/93.9%/81.5%, respectively. Thus, the highest specificity and PPV were confirmed for the IgAG assay. Improvements in the sensitivity and NPV were achieved by "at least one positive" analysis with the GM and BG assays, with the sensitivity/specificity/PPV/NPV values being 85.0%/69.6%/71.4%/84.2%. Nevertheless, the highest sensitivity and NPV were achieved by the "at least one positive" analysis combining the GM, BG and IgAG tests (97.6% and 96.8%, respectively). The involvement of the IgAG assay could improve IPA diagnosis in non-neutropenic patients by increasing the sensitivity and NPV when combined with the GM or BG assays. Furthermore, improvement was achieved by combining the GM, BG and IgAG assays using the "at least one positive test" strategy, especially if doubt exists.

Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava Ostrava Czech Republic Department of Anesthesiology and Intensive Care Medicine University Hospital Ostrava Ostrava Czech Republic Department of Intensive Medicine Emergency Medicine and Forensic Studies University of Ostrava Ostrava Czech Republic

Department of Immunology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic Center of Health Services Institute of Public Health in Ostrava Ostrava Czech Republic Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava Ostrava Czech Republic

Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic Laboratory of Mycology Department of Parasitology Mycology and Mycobacteriology Prague Public Health Institute in Usti nad Labem Prague Czech Republic

Laboratory of Clinical Mycology Bacteriology and Mycology Institute of Public Health in Ostrava Ostrava Czech Republic

Laboratory of Clinical Mycology Bacteriology and Mycology Institute of Public Health in Ostrava Ostrava Czech Republic Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Lung Department Krnov Combined Medical Facility Krnov Czech Republic

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000851
003      
CZ-PrNML
005      
20211208135418.0
007      
ta
008      
190107s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1111/myc.12765 $2 doi
035    __
$a (PubMed)29575150
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Dobias, R $u Laboratory of Clinical Mycology, Bacteriology and Mycology, Institute of Public Health in Ostrava, Ostrava, Czech Republic. Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
245    10
$a Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients / $c R. Dobias, P. Jaworska, H. Tomaskova, M. Kanova, P. Lyskova, Z. Vrba, C. Holub, L. Svobodová, P. Hamal, M. Raska,
520    9_
$a Detection of serum galactomannan (GM) and (1,3)-β-d-glucan (BG) is considered useful for non-culture diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients. Only few studies evaluated these seromarkers in non-neutropenic patients suspected of having IPA. The aim of this study was to evaluate both tests together with the Aspergillus fumigatus-specific serum IgG and IgA (IgAG) test for serological IPA diagnosis in non-neutropenic patients. Sera from 87 patients suspected of having IPA were retrospectively analysed. Patients were categorised into groups of proven IPA (n = 10), putative IPA (n = 31) and non-IPA colonisation (n = 46). When the GM, BG and IgAG assays were used for patients included in the study, the sensitivity/specificity/positive predictive value (PPV)/negative predictive value (NPV) were 48.8%/91.3%/83.3%/66.7%, 82.9%/73.9%/73.9%/82.9% and 75.6%/95.7%/93.9%/81.5%, respectively. Thus, the highest specificity and PPV were confirmed for the IgAG assay. Improvements in the sensitivity and NPV were achieved by "at least one positive" analysis with the GM and BG assays, with the sensitivity/specificity/PPV/NPV values being 85.0%/69.6%/71.4%/84.2%. Nevertheless, the highest sensitivity and NPV were achieved by the "at least one positive" analysis combining the GM, BG and IgAG tests (97.6% and 96.8%, respectively). The involvement of the IgAG assay could improve IPA diagnosis in non-neutropenic patients by increasing the sensitivity and NPV when combined with the GM or BG assays. Furthermore, improvement was achieved by combining the GM, BG and IgAG assays using the "at least one positive test" strategy, especially if doubt exists.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protilátky fungální $x krev $7 D000908
650    _2
$a Aspergillus fumigatus $x chemie $x imunologie $7 D001232
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin A $x krev $7 D007070
650    _2
$a imunoglobulin G $x krev $7 D007074
650    _2
$a invazivní plicní aspergilóza $x diagnóza $7 D055744
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mannany $x krev $7 D008351
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a sérum $x chemie $7 D044967
650    _2
$a mladý dospělý $7 D055815
650    _2
$a beta-glukany $x krev $7 D047071
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Jaworská, Pavla $7 xx0234083 $u Laboratory of Clinical Mycology, Bacteriology and Mycology, Institute of Public Health in Ostrava, Ostrava, Czech Republic.
700    1_
$a Tomaskova, H $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. Center of Health Services, Institute of Public Health in Ostrava, Ostrava, Czech Republic. Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Kanova, M $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic. Department of Intensive Medicine, Emergency Medicine and Forensic Studies, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Lysková, Pavlína $7 xx0234045 $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. Laboratory of Mycology, Department of Parasitology, Mycology and Mycobacteriology Prague, Public Health Institute in Usti nad Labem, Prague, Czech Republic.
700    1_
$a Vrba, Z $u Lung Department, Krnov Combined Medical Facility, Krnov, Czech Republic.
700    1_
$a Holub, C $u Lung Department, Krnov Combined Medical Facility, Krnov, Czech Republic.
700    1_
$a Svobodová, Lada $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. $7 xx0267259
700    1_
$a Hamal, P $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Raska, M $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
773    0_
$w MED00010272 $t Mycoses $x 1439-0507 $g Roč. 61, č. 8 (2018), s. 576-586
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29575150 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20211208135417 $b ABA008
999    __
$a ok $b bmc $g 1364843 $s 1038974
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 61 $c 8 $d 576-586 $e 20180611 $i 1439-0507 $m Mycoses $n Mycoses $x MED00010272
LZP    __
$a Pubmed-20190107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...